González-Cofrade, L.; Cuadrado, I.; Amesty, Á.; Estévez-Braun, A.; de las Heras, B.; Hortelano, S.
Dehydroisohispanolone as a Promising NLRP3 Inhibitor Agent: Bioevaluation and Molecular Docking. Pharmaceuticals 2022, 15, 825.
https://doi.org/10.3390/ph15070825
AMA Style
González-Cofrade L, Cuadrado I, Amesty Á, Estévez-Braun A, de las Heras B, Hortelano S.
Dehydroisohispanolone as a Promising NLRP3 Inhibitor Agent: Bioevaluation and Molecular Docking. Pharmaceuticals. 2022; 15(7):825.
https://doi.org/10.3390/ph15070825
Chicago/Turabian Style
González-Cofrade, Laura, Irene Cuadrado, Ángel Amesty, Ana Estévez-Braun, Beatriz de las Heras, and Sonsoles Hortelano.
2022. "Dehydroisohispanolone as a Promising NLRP3 Inhibitor Agent: Bioevaluation and Molecular Docking" Pharmaceuticals 15, no. 7: 825.
https://doi.org/10.3390/ph15070825
APA Style
González-Cofrade, L., Cuadrado, I., Amesty, Á., Estévez-Braun, A., de las Heras, B., & Hortelano, S.
(2022). Dehydroisohispanolone as a Promising NLRP3 Inhibitor Agent: Bioevaluation and Molecular Docking. Pharmaceuticals, 15(7), 825.
https://doi.org/10.3390/ph15070825